These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28719234)

  • 1. The In Vivo Effects of the CB
    Cairns EA; Szczesniak AM; Straiker AJ; Kulkarni PM; Pertwee RG; Thakur GA; Baldridge WH; Kelly MEM
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):582-590. PubMed ID: 28719234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action.
    Oltmanns MH; Samudre SS; Castillo IG; Hosseini A; Lichtman AH; Allen RC; Lattanzio FA; Williams PB
    J Ocul Pharmacol Ther; 2008 Feb; 24(1):104-15. PubMed ID: 18201139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and pharmacological profiling of cannabinoid 1 receptor allosteric modulators: Preclinical efficacy of C2-group GAT211 congeners for reducing intraocular pressure.
    Garai S; Schaffer PC; Laprairie RB; Janero DR; Pertwee RG; Straiker A; Thakur GA
    Bioorg Med Chem; 2021 Nov; 50():116421. PubMed ID: 34634617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation.
    Thapa D; Cairns EA; Szczesniak AM; Kulkarni PM; Straiker AJ; Thakur GA; Kelly MEM
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31968549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure.
    Szczesniak AM; Maor Y; Robertson H; Hung O; Kelly ME
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):427-35. PubMed ID: 21770780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantiomer-specific positive allosteric modulation of CB
    Mitjavila J; Yin D; Kulkarni PM; Zanato C; Thakur GA; Ross R; Greig I; Mackie K; Straiker A
    Pharmacol Res; 2018 Mar; 129():475-481. PubMed ID: 29158048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.
    Slivicki RA; Xu Z; Kulkarni PM; Pertwee RG; Mackie K; Thakur GA; Hohmann AG
    Biol Psychiatry; 2018 Nov; 84(10):722-733. PubMed ID: 28823711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model.
    Laprairie RB; Bagher AM; Rourke JL; Zrein A; Cairns EA; Kelly MEM; Sinal CJ; Kulkarni PM; Thakur GA; Denovan-Wright EM
    Neuropharmacology; 2019 Jun; 151():1-12. PubMed ID: 30940536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor.
    Laprairie RB; Kulkarni PM; Deschamps JR; Kelly MEM; Janero DR; Cascio MG; Stevenson LA; Pertwee RG; Kenakin TP; Denovan-Wright EM; Thakur GA
    ACS Chem Neurosci; 2017 Jun; 8(6):1188-1203. PubMed ID: 28103441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid receptor 1 positive allosteric modulator (GAT229) attenuates cisplatin-induced neuropathic pain in mice.
    Bagher AM; Binmahfouz LS; Shaik RA; Eid BG
    Saudi Pharm J; 2023 Feb; 31(2):255-264. PubMed ID: 36942271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect sympatholytic actions at β-adrenoceptors account for the ocular hypotensive actions of cannabinoid receptor agonists.
    Hudson BD; Beazley M; Szczesniak AM; Straiker A; Kelly ME
    J Pharmacol Exp Ther; 2011 Dec; 339(3):757-67. PubMed ID: 21885619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of topical CB1 agonist WIN 55212-2 on retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat.
    Pinar-Sueiro S; Zorrilla Hurtado JÁ; Veiga-Crespo P; Sharma SC; Vecino E
    Exp Eye Res; 2013 May; 110():55-8. PubMed ID: 23454099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive allosteric modulation of the cannabinoid CB
    Green HM; Manning JJ; Greig IR; Ross RA; Finlay DB; Glass M
    Br J Pharmacol; 2024 Oct; 181(19):3642-3662. PubMed ID: 38831545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2.
    Song ZH; Slowey CA
    J Pharmacol Exp Ther; 2000 Jan; 292(1):136-9. PubMed ID: 10604940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive allosteric modulation of type 1 cannabinoid receptors reduces spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg.
    Roebuck AJ; Greba Q; Smolyakova AM; Alaverdashvili M; Marks WN; Garai S; Baglot SL; Petrie G; Cain SM; Snutch TP; Thakur GA; Hill MN; Howland JG; Laprairie RB
    Neuropharmacology; 2021 Jun; 190():108553. PubMed ID: 33845076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that cannabinoid CB1 receptors regulate intraocular pressure via two opposing mechanisms.
    Miller S; Daily L; Ploss M; Greig I; Ross R; Rayana NP; Dai J; Sugali CK; Mao W; Straiker A
    Exp Eye Res; 2020 Nov; 200():108241. PubMed ID: 32941875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects.
    Ignatowska-Jankowska BM; Baillie GL; Kinsey S; Crowe M; Ghosh S; Owens RA; Damaj IM; Poklis J; Wiley JL; Zanda M; Zanato C; Greig IR; Lichtman AH; Ross RA
    Neuropsychopharmacology; 2015 Dec; 40(13):2948-59. PubMed ID: 26052038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action.
    Cawston EE; Redmond WJ; Breen CM; Grimsey NL; Connor M; Glass M
    Br J Pharmacol; 2013 Oct; 170(4):893-907. PubMed ID: 23937487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CB
    Trexler KR; Eckard ML; Kinsey SG
    Pharmacol Biochem Behav; 2019 Feb; 177():27-33. PubMed ID: 30597181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric modulators restore orthosteric agonist binding to mutated CB
    Dopart R; Kendall DA
    J Pharm Pharmacol; 2020 Jan; 72(1):84-91. PubMed ID: 31722122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.